Clinicopathological Characteristics and Prognostic Implications of Periodic Acid-Schiff-Positive Amyloid Deposits in Renal AL Amyloidosis
Kidney Diseases · 15.06.2026 · 12 (1) · 635-647
DOI: 10.1159/000552894 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney Diseases, online erschienen am 15.06.2026. Verfasst von Yueyue Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Electron Microscopy, Pathological Center, Peking University First Hospital, Beijing, China. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
It has been recognized that periodic acid-Schiff (PAS) staining of amyloid deposits is typically weak or negative in the majority of AL amyloidosis. However, a subset of patients exhibits PAS-positive deposits, and their clinicopathological significance remains unclear.
Methods
We retrospectively analyzed 269 patients with renal biopsy-proven AL amyloidosis from our institution; 72 were classified as PAS positive and 197 as PAS negative. Baseline demographics, clinical data, renal pathology features, treatment strategies, and prognostic information were collected. Multivariable linear regression and Cox proportional hazards models were used to determine the impact of PAS-positive amyloid deposition on renal function and patients’ outcomes.
Results
Compared with the PAS-negative group, PAS-positive patients had higher serum creatinine (94.40 vs. 79 μmol/L, p = 0.005) and increased renal insufficiency ratio (31.94% vs. 14.72%, p = 0.002). Histopathology showed more severe glomerular and interstitial amyloid deposition (p = 0.037, p = 0.049, respectively). In multivariable linear regression, PAS-positive deposits (β = 0.158, p = 0.005) were independently associated with higher serum creatinine. PAS-positive patients showed significantly worse renal survival (HR: 3.05, 95% CI: 1.40–6.65, p = 0.005), independent of age, treatment regimens, renal stage, and pathological cores. Meanwhile, PAS-positive staining was an adverse prognostic factor (HR: 2.34, 95% CI: 1.24–4.43, p = 0.009) for overall survival after adjusting for AL type, age, treatment, organ involvement, interstitial fibrosis and tubular atrophy, and total amyloid burden.
Conclusion
PAS-positive amyloid deposits are associated with more severe renal injury and poorer prognosis in AL amyloidosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Electron Microscopy, Pathological Center, Peking University First Hospital, Beijing, China.
- Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
- Renal Pathological Center, Institute of Nephrology, Peking University, Beijing, China.
- Key Laboratory of Renal Diseases, Ministry of Health of China, Beijing, China.
- Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China.
- Department of Nephrology, Fuxing Hospital, The Eighth Clinical Medical College, Capital Medical University, Beijing, China.
Zitieren
APA
Zhu, Y., Yao, Y., Chen, K., Zhou, W., Li, D., Zhu, X., Wang, S., Yu, X., Zhang, X., Zhou, F., & Wang, S. (2026). Clinicopathological Characteristics and Prognostic Implications of Periodic Acid-Schiff-Positive Amyloid Deposits in Renal AL Amyloidosis. Kidney Diseases, 12(1), 635-647. https://doi.org/10.1159/000552894
Vancouver
Zhu Y, Yao Y, Chen K, Zhou W, Li D, Zhu X, et al. Clinicopathological Characteristics and Prognostic Implications of Periodic Acid-Schiff-Positive Amyloid Deposits in Renal AL Amyloidosis. Kidney Diseases. 2026;12(1):635-647. doi:10.1159/000552894
BibTeX
@article{Zhu2026,
author = {Zhu, Yueyue and Yao, Ying and Chen, Kai and Zhou, Weixin and Li, Danyang and Zhu, Xiaojuan and Wang, Shuang and Yu, Xiaojuan and Zhang, Xin and Zhou, Fude and Wang, Suxia},
title = {Clinicopathological Characteristics and Prognostic Implications of Periodic Acid-Schiff-Positive Amyloid Deposits in Renal AL Amyloidosis},
journal = {Kidney Diseases},
year = {2026},
volume = {12},
number = {1},
pages = {635--647},
doi = {10.1159/000552894}
}
EUVIMED